中国与西方人群头颈癌及宫颈癌的突变图谱比较
该研究纳入51例头颈鳞癌(SYSU-HNSC)和38例宫颈鳞癌(SYSU-CESC)中国患者,用YuanSuTM450基因面板检测基因组变异,并与TCGA西方人群比较。结果发现SYSU-HNSC中FGFR3突变为具有治疗潜力的新靶点,SYSU-CESC中KMT2C、KMT2D、KDM5C、KMT2A等表观遗传调控相关基因突变频繁。研究为中国人群头颈癌和宫颈癌的基因图谱提供了无偏见解,并提示可能使中国患者获益的潜在新治疗靶点。
要点
- 研究比较了中国SYSU队列与西方TCGA队列头颈鳞癌和宫颈鳞癌的基因突变谱。
- SYSU-HNSC中FGFR3突变被鉴定为具有治疗潜力的新靶点。
- SYSU-CESC中KMT2C、KMT2D、KDM5C、KMT2A等表观遗传调控相关基因突变频繁。
核心结论
- 研究为中国人群头颈鳞癌和宫颈鳞癌的基因图谱提供了无偏见解,并提示可能使中国患者获益的潜在新治疗靶点。
研究设计与样本
- 研究纳入51例头颈鳞癌患者(SYSU-HNSC)和38例宫颈鳞癌患者(SYSU-CESC),使用YuanSuTM450基因面板(OrigiMed,上海,中国)检测基因组变异,并与TCGA西方人群队列比较。
主要发现
- 与TCGA-HNSC队列相比,SYSU-HNSC中FGFR3突变被鉴定为具有治疗潜力的新靶点。
- 与TCGA-CESC队列相比,SYSU-CESC队列中KMT2C、KMT2D、KDM5C、KMT2A等表观遗传调控相关基因突变频繁。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to unbiasedly map the genetic mutation profile of HNSC and CESC associated with HPV status in the Chinese population (SYSU-cohort) and compare them with Western population (TCGA-cohort). METHODS: Fifty-one HNSC patients (SYSU-HNSC) and 38 CESC patients (SYSU-CESC) were enrolled in this study. Genomic alterations were examined, and the profile was produced using the YuanSuTM450 gene panel (OrigiMed, Shanghai, China). The altered genes were inferred and compared to Western patients from TCGA cohorts. RESULTS: Compared to the TCGA-HNSC cohort, FGFR3 mutation was identified as a novel target in SYSU-HNSC with therapeutic potential. Compared to the TCGA-CESC cohort, some epigenetic regulation-associated genes were frequently mutated in SYSU-CESC cohort (KMT2C, KMT2D, KDM5C, KMT2A). CONCLUSION: In summary, our study provides unbiased insights into the genetic landscape of HNSC and CESC in the Chinese population and highlights potential novel therapeutic targets that may benefit Chinese patients.
引用
- Li Q, Zhu G, Zhang L, et al. Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population. Head Neck. 2023. PMID: 38111234. doi:10.1002/hed.27603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。